Jack Meehan
Stock Analyst at Barclays
(4.90)
# 71
Out of 4,479 analysts
80
Total ratings
71.25%
Success rate
23.02%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $125.78 | -0.62% | 10 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $284.49 | +1.23% | 8 | Aug 3, 2023 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | n/a | $136.64 | - | 5 | Apr 23, 2020 | |
| LH Labcorp Holdings | Maintains: Overweight | n/a | $202.73 | - | 7 | Apr 23, 2020 | |
| ICLR ICON PLC | Maintains: Overweight | n/a | $318.30 | - | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | n/a | $24.76 | - | 6 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | n/a | $207.47 | - | 4 | Mar 26, 2020 | |
| INMD InMode | Maintains: Overweight | n/a | $17.41 | - | 1 | Mar 26, 2020 | |
| ILMN Illumina | Maintains: Overweight | n/a | $105.51 | - | 7 | Mar 26, 2020 | |
| HOLX Hologic | Maintains: Equal-Weight | n/a | $73.53 | - | 4 | Mar 26, 2020 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | n/a | $201.48 | - | 3 | Mar 26, 2020 | |
| BIO Bio-Rad Laboratories | Maintains: Overweight | n/a | $267.55 | - | 1 | Mar 26, 2020 | |
| AVTR Avantor | Maintains: Overweight | n/a | $20.58 | - | 1 | Mar 26, 2020 | |
| QDEL QuidelOrtho | Downgrades: Equal-Weight | n/a | $31.36 | - | 9 | Mar 26, 2020 | |
| BRKR Bruker | Upgrades: Overweight | n/a | $61.64 | - | 2 | Mar 26, 2020 | |
| MTD Mettler-Toledo International | Upgrades: Equal-Weight | n/a | $1,357.07 | - | 2 | Mar 26, 2020 | |
| TMO Thermo Fisher | Maintains: Overweight | n/a | $533.93 | - | 5 | Mar 18, 2019 | |
| BRO Brown & Brown | Maintains: Underweight | n/a | $89.65 | - | 2 | Nov 12, 2018 | |
| INCR InterCure | Initiates: Equal-Weight | n/a | $2.05 | - | 1 | Dec 11, 2017 |
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $125.78
Upside: -0.62%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $284.49
Upside: +1.23%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $136.64
Upside: -
Labcorp Holdings
Apr 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $202.73
Upside: -
ICON PLC
Apr 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $318.30
Upside: -
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: n/a
Current: $24.76
Upside: -
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $207.47
Upside: -
InMode
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $17.41
Upside: -
Illumina
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $105.51
Upside: -
Hologic
Mar 26, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $73.53
Upside: -
Charles River Laboratories International
Mar 26, 2020
Maintains: Equal-Weight
Price Target: n/a
Current: $201.48
Upside: -
Bio-Rad Laboratories
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $267.55
Upside: -
Avantor
Mar 26, 2020
Maintains: Overweight
Price Target: n/a
Current: $20.58
Upside: -
QuidelOrtho
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $31.36
Upside: -
Bruker
Mar 26, 2020
Upgrades: Overweight
Price Target: n/a
Current: $61.64
Upside: -
Mettler-Toledo International
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: n/a
Current: $1,357.07
Upside: -
Thermo Fisher
Mar 18, 2019
Maintains: Overweight
Price Target: n/a
Current: $533.93
Upside: -
Brown & Brown
Nov 12, 2018
Maintains: Underweight
Price Target: n/a
Current: $89.65
Upside: -
InterCure
Dec 11, 2017
Initiates: Equal-Weight
Price Target: n/a
Current: $2.05
Upside: -